OneDigital Investment Advisors LLC Has $632,000 Stock Position in CME Group Inc. (NASDAQ:CME)

OneDigital Investment Advisors LLC cut its position in CME Group Inc. (NASDAQ:CME) by 11.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,866 shares of the financial services provider’s stock after selling 362 shares during the quarter. OneDigital Investment Advisors LLC’s holdings in CME Group were worth $632,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Y.D. More Investments Ltd acquired a new position in shares of CME Group during the 2nd quarter worth approximately $36,000. Thurston Springer Miller Herd & Titak Inc. increased its stake in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares during the period. McClarren Financial Advisors Inc. raised its holdings in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 78 shares in the last quarter. Asset Dedication LLC raised its holdings in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares in the last quarter. Finally, New Covenant Trust Company N.A. acquired a new stake in shares of CME Group during the 1st quarter worth $82,000. 87.75% of the stock is owned by institutional investors.

CME Group Stock Down 0.7 %

CME Group stock opened at $228.00 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $82.16 billion, a P/E ratio of 23.97, a P/E/G ratio of 5.20 and a beta of 0.55. The firm has a 50 day moving average price of $223.21 and a 200-day moving average price of $210.81. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.74.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company earned $2.25 earnings per share. As a group, equities analysts predict that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.02%. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

Analyst Ratings Changes

CME has been the topic of several recent analyst reports. The Goldman Sachs Group lifted their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. JPMorgan Chase & Co. lifted their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Morgan Stanley increased their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Piper Sandler increased their price target on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Finally, TD Cowen started coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $224.47.

Insider Activity

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the transaction, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. The trade was a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.